z.chowdhury
Submits third-party assay reports on material purchased directly. Based in Uppsala.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
14
n=14
Annotations
0
n=0
Median purity submitted
99.26%
n=14
Suppliers covered
9
n=14
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042171 | Semaglutide | Homopeptide | HOMO-2604-X8921 | Janoshik | 2026-Q3 | 99.41 | 4.43 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041326 | Semaglutide | WWB | WWB-2606-N3192 | PeptideMeter | 2026-Q3 | 99.09 | 4.84 | 105.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043392 | BPC-157 | WXT | WXT-2603-K3648 | Janoshik | 2026-Q2 | 97.56 | 4.79 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-042024 | Ipamorelin | TFC | TFC-2603-M6766 | Janoshik | 2026-Q2 | 99.93 | 4.48 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041611 | Tirzepatide | QSC | QSC-2511-N7625 | Janoshik | 2026-Q1 | 99.58 | 2.31 | — | Laboratory-retained | 0 | PASS |
| AX-2026-043377 | Gonadorelin | CPC | CPC-2508-B3242 | Janoshik | 2026-Q1 | 99.49 | 4.32 | 106.5 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020512 | TB-500 | KP | KP-2510-V5596 | Janoshik | 2025-Q4 | 99.11 | 4.53 | 103.3 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019674 | Tirzepatide | Homopeptide | HOMO-2509-U2115 | Nordanalyt | 2025-Q4 | 99.06 | 2.14 | 94.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019316 | Retatrutide | TFC | TFC-2508-H7325 | Medutest | 2025-Q3 | 98.04 | 3.52 | 93.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018681 | Dihexa | QYB | QYB-2503-Y6694 | Medutest | 2025-Q3 | 99.88 | 7.09 | 100.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021271 | Pemvidutide | BCH | BCH-2506-G6608 | Janoshik | 2025-Q3 | 97.99 | 6.33 | — | Laboratory-retained | 3 | MARGINAL |
| AX-2025-018650 | Semaglutide | QYB | QYB-2410-V5649 | Janoshik | 2025-Q1 | 99.93 | 3.93 | 89.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004273 | GHRP-6 | QYB | QYB-2410-S5114 | Janoshik | 2024-Q4 | 99.85 | 5.96 | 93.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005146 | Selank | KP | KP-2405-H5398 | Janoshik | 2024-Q3 | 98.63 | 7.16 | 94.4 | Supplier-supplied | 0 | FAIL |